EMA grants accelerated assessment to Ariad’s leukaemia drug
Could cut months off approval decision for ponatinib
Read MoreSection: Sales
Astellas wins US approval for prostate cancer drug Xtandi
Pharma company and its partner Medivation gain FDA licence for type of late-stage prostate cancer
Read More
Lilly appoints Michael Harrington SVP and general counsel
Replaces Robert Armitage who retires from the pharma company
Read More
Almirall strikes UK commercial partnership with Quintiles
Agreement will focus on the promotion of Almirall’s respiratory portfolio in the UK
Read More
Pharma advertising needs a new kind of creative idea
Adapting the ‘creative idea’ to this brave new, multichannel world
Read More